Literature DB >> 31025160

Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014.

Félix de la Fuente-Gonzalo1, Jorge M Nieto1, Ana Villegas1, Fernando A González1, Rafael Martínez1, Paloma Ropero2.   

Abstract

The hemoglobinopathies are a group of disorders passed down through families (inherited) in which there is abnormal production or structure of the hemoglobin molecule. They are among the most common inherited diseases around the world. Those that produce abnormal hemoglobin are called structural hemoglobinopathies while thalassemia is another type of disorder that is caused by a defect in the gene production of the globin chains. In a study ambispective comprising 1623 patients, 153 subjects showed an abnormal hemoglobin and 1470 with hypochromic and microcytic anemia, and of these 1470, 23 patients were studied for simultaneously α-thalassemias and structural hemoglobinopathies. Among the α-thalassaemia cases, 1282 cases (87.2%) were deletional α-thalassemia, 172 cases (11.7%) were non-deletional α-thalassemia, and 16 cases (1.1%) were deletional and non-deletional α-thalassamias simultaneously. Thus, approximately 12% of the cases were non-deletional α-thalassaemia. Clinical diagnosis, only 19 severe cases (1 hydrops fetalis and 18 instances of Hb H disease), 1200 thalassamias traits, and 160 thalassaemia silent carriers were recorded within the α-thalassaemia. Regarding structural hemoglobinopathies, there were only 2 cases of hemoglobinopathies with low oxygen affinity and 1 case of hemoglobin M; the remaining 150 were silent hemoglobinopathies. Non-deletional α-thalassaemia represented 12% of all α-thalassemias in our region; the most common deletion in our area was the 3.7-kb deletions, followed by Asian --(SEA) and --(FIL). The alterations responsible for non-deletional α-thalassaemia are most represented by the Hph and Hb Groene Hart and, in the case of structural hemoglobinopathies, Hb Le Lamentin and Hb J-Paris.

Entities:  

Keywords:  Alpha thalassemia; Deletion and non-deletion; Molecular diagnosis; Structural hemoglobinopathies

Mesh:

Substances:

Year:  2019        PMID: 31025160     DOI: 10.1007/s00277-019-03696-w

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Alpha-globin gene mutation spectrum in patients with microcytic hypochromic anemia from Mazandaran Province, Iran.

Authors:  Seyed Mohammad Bagher Hashemi-Soteh; Hossein Karami; Seyed Saeid Mousavi; Touraj Farazmandfar; Ahmad Tamadoni
Journal:  J Clin Lab Anal       Date:  2019-09-02       Impact factor: 3.124

2.  β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain.

Authors:  Paloma Ropero; Fernando Ataúlfo González Fernández; Jorge M Nieto; Williana Melissa Torres-Jiménez; Celina Benavente
Journal:  Front Med (Lausanne)       Date:  2022-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.